{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:36:09Z","timestamp":1793763369370,"version":"4.6.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,30]],"date-time":"2018-06-30T00:00:00Z","timestamp":1530316800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13000-018-0720-1","type":"journal-article","created":{"date-parts":[[2018,6,30]],"date-time":"2018-06-30T13:21:21Z","timestamp":1530364881000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Late recurrence of pStage 1 low-grade serous ovarian tumor presenting as a symptomatic bone metastasis: a case report"],"prefix":"10.1186","volume":"13","author":[{"given":"Chiaki","family":"Kubo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigenori","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rieko","family":"Kano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyuki","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Ohsawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ichi","family":"Nakatsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,30]]},"reference":[{"key":"720_CR1","first-page":"15","volume-title":"WHO classification of Tumours of female reproductive organs","author":"JD Seidman","year":"2014","unstructured":"Seidman JD, Bell DA, Crum CP, Gilks CB, Kurman RJ, Levine DA, et al. Tumours of the ovary: serous tumours. In: Kurman RJ, Carcangiu ML, Herrington CS, Young RH, editors. WHO classification of Tumours of female reproductive organs. Lyon: International Agency for Research on Cancer; 2014. p. 15\u201324."},{"key":"720_CR2","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1097\/PAS.0000000000000693","volume":"40","author":"G Ahn","year":"2016","unstructured":"Ahn G, Folkins AK, McKenney JK, Longacre TA. Low-grade serous carcinoma of the ovary: Clinicopathologic analysis of 52 invasive cases and identification of a possible noninvasive intermediate lesion. Am J Surg Pathol. 2016;40:1165\u201376.","journal-title":"Am J Surg Pathol"},{"key":"720_CR3","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1053\/hp.2000.8048","volume":"31","author":"JD Seidman","year":"2000","unstructured":"Seidman JD, Kurman RJ. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol. 2000;31:539\u201357.","journal-title":"Hum Pathol"},{"key":"720_CR4","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ygyno.2016.11.007","volume":"144","author":"CG Hannibal","year":"2017","unstructured":"Hannibal CG, Vang R, Junge J, Frederiksen K, Kurman RJ. Kjaer SK. A nationwide study of ovarian serous borderline tumors in Denmark 1978-2002. Risk of recurrence, and development of ovarian serous carcinoma. Gynecol Oncol. 2017;144:174\u201380.","journal-title":"Gynecol Oncol"},{"key":"720_CR5","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1097\/PAS.0000000000000824","volume":"41","author":"R Vang","year":"2017","unstructured":"Vang R, Hannibal CG, Junge J, Frederiksen K, Kjaer SK, Kurman RJ. Long-term behavior of serous borderline tumors subdivided into atypical proliferative tumors and noninvasive low-grade carcinomas: a population-based Clinicopathologic study of 942 cases. Am J Surg Pathol. 2017;41:725\u201337.","journal-title":"Am J Surg Pathol"},{"key":"720_CR6","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1097\/PAS.0b013e31822d787c","volume":"35","author":"A Ozcan","year":"2011","unstructured":"Ozcan A, Liles N, Coffey D, Shen SS, Truong LD. PAX2 and PAX8 expression in primary and metastatic m\u00fcllerian epithelial tumors: a comprehensive comparison. Am J Surg Pathol. 2011;35:1837\u201347.","journal-title":"Am J Surg Pathol"},{"key":"720_CR7","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/PAP.0b013e318234aaed","volume":"18","author":"C B\u00e1rcena","year":"2011","unstructured":"B\u00e1rcena C, Oliva E. WT1 expression in the female genital tract. Adv Anat Pathol. 2011;18:454\u201365.","journal-title":"Adv Anat Pathol"},{"key":"720_CR8","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/modpathol.3801002","volume":"21","author":"D Nonaka","year":"2008","unstructured":"Nonaka D, Tang Y, Chiriboga L, Rivera M, Ghossein R. Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms. Mod Pathol. 2008;21:192\u2013200.","journal-title":"Mod Pathol"},{"key":"720_CR9","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/01.pas.0000146025.91953.8d","volume":"29","author":"G Singer","year":"2005","unstructured":"Singer G, St\u00f6hr R, Cope L, Dehari R, Hartmann A, Cao DF, et al. Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation. Am J Surg Pathol. 2005;29:218\u201324.","journal-title":"Am J Surg Pathol"},{"key":"720_CR10","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1097\/00000478-200209000-00003","volume":"26","author":"MT Deavers","year":"2002","unstructured":"Deavers MT, Gershenson DM, Tortolero-Luna G, Malpica A, Lu KH, Silva EG. Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential: a study of 99 advanced stage cases. Am J Surg Pathol. 2002;26:1129\u201341.","journal-title":"Am J Surg Pathol"},{"key":"720_CR11","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1097\/00000478-200412000-00015","volume":"28","author":"MA Recine","year":"2004","unstructured":"Recine MA, Deavers MT, Middleton LP, Silva EG, Malpica A. Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall. Am J Surg Pathol. 2004;28:1646\u201351.","journal-title":"Am J Surg Pathol"},{"key":"720_CR12","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/01.pas.0000164030.82810.db","volume":"29","author":"TA Longacre","year":"2005","unstructured":"Longacre TA, McKenney JK, Tazelaar HD, Kempson RL, Hendrickson MR. Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up. Am J Surg Pathol. 2005;29:707\u201323.","journal-title":"Am J Surg Pathol"},{"key":"720_CR13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/PGP.0000000000000389","volume":"37","author":"D Xing","year":"2018","unstructured":"Xing D, Jenson EG, Zwick CA, Rodriguez FJ, Kurman RJ. Atypical proliferative (borderline) serous tumor in the brain: a case report. Int J Gynecol Pathol. 2018;37:52\u20136.","journal-title":"Int J Gynecol Pathol"},{"key":"720_CR14","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s00404-014-3597-6","volume":"291","author":"J Menczer","year":"2015","unstructured":"Menczer J, Schreiber L, Peled O, Levy T. Very late recurrence (after more than 20 years) of epithelial ovarian carcinoma: case report and literature review. Arch Gynecol Obstet. 2015;291:1199\u2013203.","journal-title":"Arch Gynecol Obstet"},{"key":"720_CR15","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/path.1521","volume":"202","author":"NL Sieben","year":"2004","unstructured":"Sieben NL, Macropoulos P, Roemen GM, Kolkman-Uljee SM, Jan Fleuren G, Houmadi R, et al. In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours. J Pathol. 2004;202:336\u201340.","journal-title":"J Pathol"},{"key":"720_CR16","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/path.3967","volume":"226","author":"S Jones","year":"2012","unstructured":"Jones S, Wang TL, Kurman RJ, Nakayama K, Velculescu VE, Vogelstein B, et al. Low-grade serous carcinomas of the ovary contain very few point mutations. J Pathol. 2012;226:413\u201320.","journal-title":"J Pathol"},{"key":"720_CR17","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.2353\/ajpath.2010.100212","volume":"177","author":"KK Wong","year":"2010","unstructured":"Wong KK, Tsang YT, Deavers MT, Mok SC, Zu Z, Sun C, et al. BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas. Am J Pathol. 2010;177:1611\u20137.","journal-title":"Am J Pathol"},{"key":"720_CR18","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/path.4252","volume":"231","author":"YT Tsang","year":"2013","unstructured":"Tsang YT, Deavers MT, Sun CC, Kwan SY, Kuo E, Malpica A, et al. KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma. J Pathol. 2013;231:449\u201356.","journal-title":"J Pathol"},{"key":"720_CR19","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S1470-2045(12)70572-7","volume":"14","author":"J Farley","year":"2013","unstructured":"Farley J, Brady WE, Vathipadiekal V, Lankes HA, Coleman R, Morgan MA, et al. Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study. Lancet Oncol. 2013;14:134\u201340.","journal-title":"Lancet Oncol"},{"key":"720_CR20","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1097\/IGC.0000000000000190","volume":"24","author":"RN Grisham","year":"2014","unstructured":"Grisham RN, Iyer G, Sala E, Zhou Q, Iasonos A, DeLair D, et al. Bevacizumab shows activity in patients with low-grade serous ovarian and primary peritoneal cancer. Int J Gynecol Cancer. 2014;24:1010\u20134.","journal-title":"Int J Gynecol Cancer"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-018-0720-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13000-018-0720-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-018-0720-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,20]],"date-time":"2019-10-20T06:13:15Z","timestamp":1571551995000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-018-0720-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,30]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["720"],"URL":"https:\/\/doi.org\/10.1186\/s13000-018-0720-1","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,30]]},"assertion":[{"value":"6 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for the publication of this case report. A copy of the consent form is available for review by the Editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"43"}}